Growth Factors in Ovarian Cancer
Author Information
Author(s): O.J. Owens, C. Stewart, R.E. Leake
Primary Institution: Glasgow University
Hypothesis
The study aims to measure the quantity of EGF and TGFa in tumor samples from patients with epithelial ovarian cancer and compare peptide levels based on tumor differentiation, stage, and histological subtype.
Conclusion
TGFa was found in a greater proportion of patients and in larger quantities compared to EGF, with no significant differences in levels based on tumor stage, differentiation, or type.
Supporting Evidence
- TGFa was present in 88.5% of samples, while EGF was detected in only 27.6%.
- The median values for TGFa were at least 10-fold greater than those of EGF.
- There was no statistical difference between TGFa or EGF levels and the degree of differentiation of the tumors.
- Median concentration did not differ significantly among the histological sub-groups.
Takeaway
This study looked at two growth factors in ovarian cancer and found that one of them, TGFa, was much more common and present in higher amounts than the other, EGF.
Methodology
The study involved collecting and analyzing 174 tumor samples from 133 patients, measuring EGF and TGFa levels using radioimmunoassay.
Limitations
Patient follow-up was not sufficiently long to compare peptide levels with survival.
Participant Demographics
Patients included 80 serous, 19 endometrioid, 12 mucinous, 9 clear cell, and 13 undifferentiated types, with a mean age of 59.7 years.
Want to read the original?
Access the complete publication on the publisher's website